Emory University, Nell Hodgson Woodruff School of Nursing, Atlanta, Georgia.
University of California San Francisco, School of Nursing, Community Health Systems, San Francisco, California.
J Pain. 2024 Dec;25(12):104668. doi: 10.1016/j.jpain.2024.104668. Epub 2024 Sep 5.
Many adults with sickle cell disease experience chronic, nonvaso-occlusive pain that can benefit from nonpharmacological interventions available for use in the home setting. Virtual reality (VR) has been shown to be effective in decreasing pain in chronic pain conditions and may be useful for home-based self-management of chronic pain in sickle cell. However, the literature lacks studies examining this potential. Additionally, the knowledge and experiences of adults with sickle cell who have tried VR for home-based chronic pain management have not yet been reported. This qualitative, descriptive pilot study explored the knowledge and perceptions of VR among adults with sickle cell and their experience with using in-home VR for chronic pain. Nine participants completed demographic questionnaires and an individual interview that was recorded, transcribed verbatim, and analyzed using thematic analysis. Participants were 21 to 38 years of age, and most were female (88.9%) with a medium or high sickle cell disease severity (88.9%) and a chronic pain-grade classification of grade III (high disability-moderately limiting) or grade IV (high disability-severely limiting) (55.5%). Interview themes, which aligned with the technology acceptance model, were 1) pain beliefs and self-management, 2) VR as another world, and 3) experience of using in-home VR. Based on preliminary data, VR shows promise as a strategy for nonpharmacological management of chronic pain in adults with sickle cell. However, further investigations are warranted to mitigate the challenges and limitations associated with using VR in this capacity. PERSPECTIVE: Few evidence-based, nonpharmacological interventions exist for chronic pain in adults with sickle cell disease. This first qualitative, pilot study of in-home VR for chronic pain in adults with sickle cell disease suggests that VR interventions need further exploration as a nonpharmacological strategy for mitigating their pain in the home setting.
许多镰状细胞病患者会经历慢性、非血管阻塞性疼痛,这些疼痛可以通过家庭环境中可用的非药物干预措施来缓解。虚拟现实 (VR) 已被证明可有效减轻慢性疼痛病症的疼痛,并且可能对镰状细胞病患者的家庭慢性疼痛自我管理有用。然而,目前文献中缺乏相关研究。此外,尚未有报道探讨镰状细胞病患者尝试 VR 进行家庭慢性疼痛管理的相关知识和经验。本定性描述性初步研究探讨了镰状细胞病患者对 VR 的了解和认知,以及他们使用家庭 VR 治疗慢性疼痛的体验。9 名参与者完成了人口统计学问卷和个人访谈,访谈内容被记录、逐字转录,并使用主题分析进行分析。参与者年龄在 21 至 38 岁之间,大多数为女性(88.9%),镰状细胞病严重程度为中或重度(88.9%),慢性疼痛分级为 III 级(高残疾-中度受限)或 IV 级(高残疾-严重受限)(55.5%)。与技术接受模型一致的访谈主题包括:1)疼痛信念和自我管理;2)VR 作为另一个世界;3)使用家庭 VR 的体验。基于初步数据,VR 有望成为镰状细胞病患者慢性疼痛非药物管理的策略。然而,需要进一步研究以减轻在这种情况下使用 VR 相关的挑战和限制。观点:对于镰状细胞病患者的慢性疼痛,目前几乎没有基于证据的非药物干预措施。这项针对镰状细胞病患者家庭慢性疼痛 VR 的初步定性研究表明,VR 干预措施需要进一步探索,作为减轻其家庭环境中疼痛的非药物策略。